Active Pharmaceutical Ingredients and Intermediates Catalog
Regulatory Submission
Select all that apply
Ready to move from idea to impact?
Whether you’re seeking additional information about a specific API or interested in making a purchase, our sales team can help.
Curia makes no representation, guarantee, or warranty as to the completeness or accuracy of the information in this catalog or to the patentability of these products or defenses from third party intellectual property right infringement actions. This catalog is for informational purposes only and is not an offer for sale. Nothing in this catalog should be considered as a promotion or advertisement for the sale or use of any product where the sale or use of the product infringes any valid patents or is not permitted under applicable laws and regulations.
API name
Site
Regulatory submission
There are no matches within your selected filters. Can’t find what you’re looking for? Contact us.
A
Alcaftadine
Site
Valladolid, Spain
Regulatory submission
US DMF, Korea
Alclometasone-17,21- Dipropionate
Site
Valladolid, Spain
Regulatory submission
US DMF, Japan DMF
Altrenogest
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF
Amphetamine Aspartate Monohydrate Milled
Site
Rensselaer, US
Regulatory submission
US DMF
Amphetamine Sulfate
Site
Rensselaer, US
Regulatory submission
US DMF
Argatroban
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, EU DMF
Azelastine HCl
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, EU DMF
Aztreonam (not sterile)
Site
Rozzano Valleambrosia, Italy
Regulatory submission
US DMF
Aztreonam Sterile
Site
Tonneins, France
Regulatory submission
-
B
Bamifylline HCl
Site
Bon Encontre, France
Regulatory submission
EU DMF
Beclomethasone-17,21- Dipropionate
Site
Valladolid, Spain
Regulatory submission
CEP, Russia
Beclomethasone-17,21- Dipropionate Monohydrate
Site
Valladolid, Spain
Regulatory submission
-
Betametasone-17,21- Dipropionate Sterile
Site
Valladolid, Spain
Regulatory submission
EU DMF
Betamethasone Acetate
Site
Valladolid, Spain
Regulatory submission
-
Betamethasone Base
Site
Valladolid, Spain
Regulatory submission
-
Betamethasone Benzoate
Site
Valladolid, Spain
Regulatory submission
-
Betamethasone Butyrate Propionate
Site
Valladolid, Spain
Regulatory submission
Japan DMF
Betamethasone Valerate Acetate
Site
Valladolid, Spain
Regulatory submission
-
Betamethasone-17- Valerate
Site
Valladolid, Spain
Regulatory submission
CEP, Japan DMF, Russia
Betamethasone-17,21- Dipropionate
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP, Japan DMF, China
Betamethasone-21- Phosphate Disodium Salt
Site
Valladolid, Spain
Regulatory submission
CEP, Japan DMF, Russia
Brexanalone
Site
Valladolid, Spain
Regulatory submission
US DMF
Bromocriptine Mesylate
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, CEP, India, China, Russia
Budesonide
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP, China, Russia
Budesonide Sterile
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP, China
C
Carbimazole
Site
Bon Encontre, France
Regulatory submission
EU DMF
Chlorthalidone
Site
Origgio, Italy
Regulatory submission
US DMF, CEP, India
Cibenzoline Succinate
Site
Bon Encontre, France
Regulatory submission
EU DMF
Clobetasol-17-Propionate
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP, Japan DMF, Korea
Cyclofenil
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
Japan DMF
Cyclosporine
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, CEP, Japan DMF, Korea
Cyproterone Acetate
Site
Valladolid, Spain
Regulatory submission
CEP
D
Deflazacort
Site
Valladolid, Spain
Regulatory submission
EU DMF
Deoxycholic Acid
Site
Valladolid, Spain
Regulatory submission
US DMF
Desogestrel
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
CEP, EU DMF, Russia
Dexamethasone Acetate
Site
Valladolid, Spain
Regulatory submission
-
Dexamethasone Base
Site
Valladolid, Spain
Regulatory submission
Japan DMF, Korea
Dexamethasone-17- Valerate
Site
Valladolid, Spain
Regulatory submission
Japan DMF
Dexamethasone-17,21- Dipropionate
Site
Valladolid, Spain
Regulatory submission
Japan DMF
Dexamethasone-21- Isonicotinate
Site
Valladolid, Spain
Regulatory submission
CEP, EU DMF
Dexamethasone-21- Phosphate Disodium Salt
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP
Dexmethylphenidate HCl
Site
Springfield, US
Regulatory submission
US DMF
Dextroamphetamine Saccharate
Site
Rensselaer, US
Regulatory submission
US DMF
Dextroamphetamine Sulfate
Site
Rensselaer, US
Regulatory submission
US DMF
Diatrizoate Meglumine
Site
Rensselaer, US
Regulatory submission
US DMF
Diatrizoate Sodium
Site
Rensselaer, US
Regulatory submission
US DMF
Diethylamine Salicylate
Site
Bon Encontre, France
Regulatory submission
EU DMF
Dihydroergocriptine Mesylate
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
EU DMF
Dihydroergocristine Mesylate
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
CEP
Dihydroergotamine Mesylate
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, CEP, Japan DMF
Dorzolamide
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP, Japan DMF
E
Ergotamine Tartrate
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, CEP
Ethanolamine Oleate in Solution
Site
Grafton, US
Regulatory submission
US DMF
Etonogestrel
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF
Exemestane
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP
F
Finasteride
Site
Valladolid, Spain
Regulatory submission
CEP, Korea
Fludrocortisone-21- Acetate
Site
Valladolid, Spain
Regulatory submission
US DMF
Flugestone Acetate
Site
Valladolid, Spain
Regulatory submission
EU DMF
Fluorometholone Base
Site
Valladolid, Spain
Regulatory submission
US DMF
Flutamide
Site
Origgio, Italy
Regulatory submission
US DMF, CEP, India, Russia
Fluticasone-17- Propionate
Site
Valladolid, Spain
Regulatory submission
CEP
Furosemide
Site
Aurangabad, India
Regulatory submission
US DMF, CEP, EU DMF, China
H
Hexetidine (Gexetidine in Russia)
Site
Bon Encontre, France
Regulatory submission
CEP, Russia
Hydrocortisone Aceponate
Site
Valladolid, Spain
Regulatory submission
EU DMF
Hydrocortisone Aceponate Sterile
Site
Valladolid, Spain
Regulatory submission
-
Hydrocortisone Acetate
Site
Valladolid, Spain
Regulatory submission
CEP, Russia
Hydrocortisone Base
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF
Hydrocortisone Sodium Phosphate Sterile
Site
Valladolid, Spain
Regulatory submission
EU DMF
Hydrocortisone-17-Butyrate
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF, Japan DMF
Hydrocortisone-21- Hemisuccinate
Site
Valladolid, Spain
Regulatory submission
CEP, EU DMF
Hydrocortisone-21- Phosphate Disodium Salt
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF, Japan DMF
Hydrocortisone-21- Sodium Succinate Sterile
Site
Valladolid, Spain
Regulatory submission
EU DMF, India
Hydroxyethyl Salicylate
Site
Bon Encontre, France
Regulatory submission
EU DMF
I
Isosorbide Mononitrate
Site
Aurangabad, India
Regulatory submission
CEP
L
Levocabastine
Site
Valladolid, Spain
Regulatory submission
CEP
Loteprednol Etabonate
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF, China
Loteprednol Etabonate Sterile Micronized
Site
Valladolid, Spain
Regulatory submission
US DMF, China
M
Mafenide Acetate
Site
Rensselaer, US
Regulatory submission
US DMF
Medrogestone
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
EU DMF
Medroxyprogesterone Acetate
Site
Valladolid, Spain
Regulatory submission
-
Medroxyprogesterone Acetate Sterile
Site
Valladolid, Spain
Regulatory submission
US DMF
Melengestrol Acetate
Site
Valladolid, Spain
Regulatory submission
US DMF
Meperidine HCl
Site
Rensselaer, US
Regulatory submission
US DMF
Methylphenidate HCl
Site
Springfield, US
Regulatory submission
US DMF
Methylprednisolone Aceponate
Site
Valladolid, Spain
Regulatory submission
EU DMF
Methylprednisolone Hydrogen Succinate
Site
Valladolid, Spain
Regulatory submission
EU DMF
Methylprednisolone-21- Acetate
Site
Valladolid, Spain
Regulatory submission
US DMF
Methylprednisolone-21- Acetate Sterile
Site
Valladolid, Spain
Regulatory submission
US DMF
Methylprednisolone-21- Sodium Succinate Sterile
Site
Valladolid, Spain
Regulatory submission
India
Mifepristone
Site
Valladolid, Spain
Regulatory submission
EU DMF, Japan DMF
Minocycline HCl
Site
Origgio, Italy
Regulatory submission
US DMF, CEP, Japan DMF, India, China, Russia
Mometasone-17-Furoate (Anhydrous)
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP, Japan DMF
Morniflumate
Site
Bon Encontre, France
Regulatory submission
EU DMF
N
Niflumic Acid
Site
Bon Encontre, France
Regulatory submission
CEP
Nifuratel
Site
Bon Encontre, France
Regulatory submission
EU DMF, China, Russia
Norepinephrine Bitartrate
Site
Rensselaer, US
Regulatory submission
US DMF
O
Olopatadine
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF, China
Oxandrolone
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, EU DMF
P
Paliperidone Palmitate Micronized Sterile
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF, China
Pancuronium Bromide
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, CEP
Pralidoxime Chloride
Site
Rensselaer, US
Regulatory submission
US DMF
Pramipexol
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP
Prednicarbate
Site
Valladolid, Spain
Regulatory submission
EU DMF
Prednisolone-21-Phosphate Disodium Salt
Site
Valladolid, Spain
Regulatory submission
US DMF, Japan DMF, India
Prednisone Base
Site
Valladolid, Spain
Regulatory submission
US DMF
Propacetamol HCl Sterile
Site
Bon Encontre, France
Regulatory submission
-
R
Racepinephrine HCl
Site
Rensselaer, US
Regulatory submission
US DMF
Regadenoson
Site
Springfield, US
Regulatory submission
US DMF
Ribavirin
Site
Origgio, Italy
Regulatory submission
US DMF, CEP, India
Rocuronium Bromide
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, CEP, Russia
S
Sirolimus
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, EU DMF, China
Sodium Oxybate
Site
Springfield, US
Regulatory submission
US DMF
T
Tamsulosin
Site
Valladolid, Spain
Regulatory submission
EU DMF
Tapentadol
Site
Springfield, US
Regulatory submission
US DMF
Testosterone Base
Site
Valladolid, Spain
Regulatory submission
US DMF, CEP
Testosterone Cypionate
Site
Valladolid, Spain
Regulatory submission
US DMF
Testosterone Propionate
Site
Valladolid, Spain
Regulatory submission
-
Triamcinolone Acetonide
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF, Japan DMF, India
Triamcinolone Acetonide Sterile
Site
Valladolid, Spain
Regulatory submission
US DMF, EU DMF, Japan DMF, Korea
Triamcinolone Acetonide-21-Phosphate Potassium Salt
Site
Valladolid, Spain
Regulatory submission
EU DMF
Trientine HCl
Site
Rensselaer, US
Regulatory submission
US DMF
Tyloxapol
Site
Rensselaer, US
Regulatory submission
US DMF
V
Vecuronium Bromide
Site
Rozzano Quinto de Stampi, Italy
Regulatory submission
US DMF, EU DMF, Japan DMF, China
Curia makes no representation, guarantee, or warranty as to the completeness or accuracy of the information in this catalog or to the patentability of these products or defenses from third party intellectual property right infringement actions. This catalog is for informational purposes only and is not an offer for sale. Nothing in this catalog should be considered as a promotion or advertisement for the sale or use of any product where the sale or use of the product infringes any valid patents or is not permitted under applicable laws and regulations.
This presentation regarding the potential development and manufacture of API and/or drug product (“Product”) is for informational purposes only. Curia makes no warranties of any kind, express or implied, including but not limited to any warranty of merchantabilities, fitness for a specific purpose, or non-infringement of any intellectual property rights, with respect to the Product or any information or process contained in or related to this presentation. In no event shall this presentation be deemed an offer for the sale of a Product, or an inducement for Curia’s customer to develop the Product or to infringe any third party intellectual property rights. Any decision to enter into a business relationship with Curia regarding the Product or otherwise seek to develop the Product is is solely that of Curia’s customer. Any business relationship between Curia and the customer with respect to the Product shall be documented in a separate written agreement, containing terms and conditions consistent with industry-standard for similar business relations, including but not limited to indemnification by the customer of Curia for any third party claims related to the development or sale of the Product. This presentation is the confidential information of Curia.
Any “Innovator” referenced in this presentation is a separate company from Curia and its affiliates. Any “Brand” name and trademark referenced in this presentation is owned by the corresponding Innovator or its affiliate, and Curia makes no claim of ownership or license to such names or trademarks.
Products with existing patent protection are intended for development use and Regulatory Purposes only, under 35 U.S.C. 271(e)(1) and article 10.6 of the Directive 2001/EC as amended by the Directive 2004/27/EC.
